Trials / Recruiting
RecruitingNCT06004349
Autoimmune and Autoinflammatory Genetics Study
Natural History and Genetics of VEXAS Syndrome and Related Autoinflammatory Syndromes
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 1,500 (estimated)
- Sponsor
- NYU Langone Health · Academic / Other
- Sex
- All
- Age
- 1 Month
- Healthy volunteers
- Accepted
Summary
This is an exploratory natural history protocol that will enroll patients with known genetic diseases, such as VEXAS syndrome, or as yet undiagnosed disorders of inflammation with the goal of improving our understanding of disease processes. Blood, saliva, hair, nail, or buccal samples may be collected for genetic analysis, blood samples will be obtained for immunologic and other functional studies, and a small number of subjects may undergo skin biopsy.
Detailed description
This is a single-site protocol designed to test the hypothesis that genetic factors contribute to susceptibility to human disorders of inflammation, and the hypothesis that identifying such genetic susceptibility factors will contribute to our understanding of the immunologic mechanisms of these diseases. There are 3 main objectives: Primary Objective: To discover the genetic basis of human disorders of inflammation or autoinflammatory diseases. Secondary Objective: To enumerate immunologic features and genotype-phenotype associations in specific inflammatory diseases, such as VEXAS syndrome. Tertiary/Exploratory Objective: To describe the clinical features of poorly characterized or newly defined disorders of inflammation, such as VEXAS syndrome, through the retrospective chart review of standard medical practice follow up
Conditions
Timeline
- Start date
- 2022-04-15
- Primary completion
- 2032-04-05
- Completion
- 2032-04-05
- First posted
- 2023-08-22
- Last updated
- 2025-07-09
Locations
2 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT06004349. Inclusion in this directory is not an endorsement.